Owlstone Medical Launches Breath Biopsy Tests For GI Health
Executive Summary
OMED Health, Owlstone’s new brand, will offer breath-based tests for small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption following a partnership between Owlstone Medical and Functional Gut Group.
You may also be interested in...
Minute Insight: Maestro Cues The Music With CE Mark For Moon Surgical
The Paris-based start-up has picked up a CE mark for the latest generation of its Maestro system, a tool designed to make laparoscopic surgery easier and safer.
Minute Insight: 15,000 Surgeries And More Funding For CMR Surgical
The UK-based company has just raised $165m support the ongoing commercialization of the Versius robotic platform.
Deals Shaping The Industry, August 2023
In Vivo's deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – acquisition, alliance, or financing. This month’s column covers deals announced in August 2023. Data provided by Biomedtracker.